MUVON's Phase II Announcement Featured by Fierce Biotech

MUVON Therapeutics has been featured by Fierce Biotech following the release of our positive Phase 2 data. This recognition highlights not only our team’s work, but the growing reality of regenerative medicine at scale—no longer science fiction, but a transformative force in healthcare.

Read the full article here.